课题基金 / 基金详情

项目摘要

项目成果

KAREN E. HEDIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):T淋巴细胞活化和迁移对于正常免疫功能至关重要。T淋巴细胞抗原受体-CD 3复合物(TCR)和趋化因子受体(如CXCR 4)的信号传导广泛交叉调节,然而,直到最近,对这种交叉调节的分子机制知之甚少。此外,尽管CXCR 4是普遍表达的、高度保守的并且对于T细胞的人类免疫缺陷病毒-1(HIV-1)感染是必需的,但是很少提出T淋巴细胞CXCR 4的特异性免疫功能。CXCR 4配体SDF-1在特定的解剖部位组成型表达,包括骨髓、淋巴结和肠道。因此,T细胞上的SDF-1/CXCR 4信号传导可能关键地调节这些位置中的T细胞免疫活化。我们在该资助的最后一个周期的结果(最近发表在Immunity上)表明,SDF-1刺激CXCR 4通过一种新的机制在T细胞中产生信号:通过诱导CXCR 4/TCR复合物的形成,然后利用TCR ITAM结构域和TCR相关信号分子激活Ras/ERK MAP激酶途径。我们的初步结果进一步表明,该途径动员AP-1依赖性转录因子,这些转录因子负责SDF-1共刺激T细胞产生和分泌IL-10。下面提出的实验旨在进一步表征这种新型信号通路的三个关键领域。目的1和2将测试中心假设,即SDF-1通过增强CXCR 4向也含有组成型再循环TCR分子的晚期再循环内体的运输来刺激CXCR 4/TCR复合物的形成,并且这些囊泡在MTOC和高尔基体附近的聚集允许CXCR 4/TCR复合物经由内体和/或高尔基体上的Ras-ERK途径组分发出信号。目的3将测试相关的假设,即该信号通路增强T细胞分泌IL-10,从而关键地调节免疫。总之,拟议研究的结果将表征最近发现的新机制的关键点,CXCR 4在T细胞中发出信号,并且也可能参与CXCR 4介导的迁移,整合素调节和HIV-1病理学。此外,拟议研究的结果将描述该途径对CXCR 4共刺激T细胞IL-10分泌和免疫调节的重要性,这些结果可能改善依赖于IL-10的人类自身免疫性疾病的治疗。
英文摘要
DESCRIPTION (provided by applicant): T lymphocyte activation and migration are critical for normal immune functions. Signaling by both the T lymphocyte antigen receptor-CD3 complex (TCR) and chemokine receptors such as CXCR4 are extensively cross-regulated, however, until recently little was known about the molecular mechanisms responsible for this cross-regulation. Moreover, although CXCR4 is ubiquitously-expressed, highly conserved, and essential for Human Immunodeficiency Virus-1 (HIV-1) infection of T cells, few specific immune function(s) of T lymphocyte CXCR4 have been proposed. The CXCR4 ligand, SDF-1, is constitutively expressed at specific anatomic sites, include the bone marrow, lymph nodes, and gut. SDF-1/CXCR4 signaling on T cells may, therefore, critically modulate T cell immune activation in these locations. Our results during the last cycle of this grant (recently published in Immunity) indicate that SDF-1 stimulation of CXCR4 produces signals in T cells via a novel mechanism: by inducing the formation of CXCR4/TCR complexes which then utilize the TCR ITAM domains and TCR-associated signaling molecules to activate the Ras/ERK MAP kinase pathway. Our preliminary results further indicate that this pathway mobilizes AP-1-dependent transcription factors that are responsible for SDF-1 co-stimulation of IL-10 production and secretion by T cells. Experiments proposed below are designed to further characterize three key areas of this novel signaling pathway. Aims 1 & 2 will test the central hypothesis that SDF-1 stimulates .the formation of CXCR4/TCR complexes by enhancing the trafficking of CXCR4 into late recycling endosomes that also contain constitutively-recycling TCR molecules, and that the clumping of these vesicles near the MTOC and Golgi permits CXCR4/TCR complexes to signal via Ras-ERK pathway components on the endosomes and/or Golgi. Aim 3 will test the related hypothesis that this signaling pathway enhances T cell secretion of IL-10 and thereby critically modulates immunity. Together, the results of the proposed studies will characterize key points of the recently-discovered novel mechanism by which CXCR4 signals in T cells, and that may also participate in CXCR4-mediated migration, integrin regulation and HIV-1 pathobiology. In addition, the results of the proposed studies will delineate the importance of this pathway for CXCR4 co-stimulation of T cell IL-10 secretion and immune regulation, results that have the potential improve therapies of human autoimmune diseases that depend on IL-10.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting osteoblasts to inhibit AML
  • 批准号:
    9058501
  • 项目类别:
  • 资助金额:
    $17.29万
  • 财政年份:
    2015
  • 负责人:
    KAREN E. HEDIN
  • 依托单位:
CXCR4 Chemokine Receptor regulation of ERK MAP Kinase
  • 批准号:
    6796264
  • 项目类别:
  • 资助金额:
    $28.9万
  • 财政年份:
    1999
  • 负责人:
    KAREN E. HEDIN
  • 依托单位:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
  • 批准号:
    8464135
  • 项目类别:
  • 资助金额:
    $29.92万
  • 财政年份:
    1999
  • 负责人:
    KAREN E. HEDIN
  • 依托单位:
CXCR4 Chemokine Receptor regulation of ERK MAP Kinase
  • 批准号:
    6942985
  • 项目类别:
  • 资助金额:
    $27.46万
  • 财政年份:
    1999
  • 负责人:
    KAREN E. HEDIN
  • 依托单位:
海外基金